Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
46,881,394
-
Share change
-
+26,539,605
-
Total reported value
-
$426,148,000
-
Put/Call ratio
-
62%
-
Price per share
-
$9.09
-
Number of holders
-
89
-
Value change
-
+$242,694,445
-
Number of buys
-
62
-
Number of sells
-
28
Institutional Holders of ENDOCYTE INC - COM (ECYT) as of Q1 2018
As of 31 Mar 2018,
ENDOCYTE INC - COM (ECYT) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,881,394 shares.
The largest 10 holders included
venBio Select Advisor LLC, Partner Fund Management, L.P., VHCP Management II, LLC, RA CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, and Ghost Tree Capital, LLC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.